Industry News
T cell boosting therapy expands into oncology
- BioPharma-Reporter.com
US FDA grants orphan drug designation for Hyleukin-7, an immuno-oncology agent that boosts T cell production and functionality, for the treatment of ICL.
https://www.biopharma-reporter.com/Article/2019/04/23/T-cell-amplifier-receives-orphan-drug-designation?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright